Rabiwon Tablet

Adult dose

Typically given orally as 1 tablet twice daily, regardless of meals, before breakfast and at bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet twice a day or 2 tablets once a day at bedtime. Particularly for duodenal ulcer patients, administering 2 tablets twice a day before breakfast and at bedtime may achieve a higher cure rate. 2) Gastroesophageal reflux disease For 8 weeks, administer 1 tablet, twice daily, or 2 tablets once at bedtime.

This medication should not be administered to patients with impaired kidney function or those undergoing dialysis. Patients who have had allergic reactions to this drug or its components should also avoid its use. It should not be given to patients with a history of acute porphyria, as it may worsen symptoms. It is safer to avoid use in patients who have had upper gastrointestinal surgery, in pregnant women or those who may become pregnant, and in premature infants and newborns. Patients on a diet that restricts potassium intake should not take this medication. Caution is advised for patients with impaired liver function, those who have previously had drug hypersensitivity, elderly patients, and patients with kidney problems. Particularly, regular monitoring is necessary when taking this medication along with non-steroidal anti-inflammatory drugs due to the risk of gastrointestinal bleeding. This medication can mask symptoms of gastric cancer, so gastric ulcer patients or middle-aged individuals with recent dyspeptic symptoms should confirm malignancy before treatment. Patients with gastric or duodenal ulcers caused by Helicobacter pylori infection require bacterial eradication therapy. Caution is required for seriously ill patients, those with hypophosphatemia, and dysphagia patients, as the component sucralfate may cause bezoars or respiratory complications. During treatment with this medication, allergic reactions, skin rashes, blood abnormalities, liver function abnormalities, cardiac arrhythmias, gastrointestinal symptoms, and neurological abnormalities may occur. If any unusual symptoms arise, immediate consultation with healthcare professionals is necessary. Long-term use should be avoided and if no therapeutic effect is observed, it is advisable to switch to another medication. Regular blood tests, liver function tests, and kidney function tests should also be performed. Elderly patients, those with chronic lung disease, diabetes, and patients with compromised immunity should be cautious as the risk of developing pneumonia may increase with this medication. If dizziness or drowsiness occurs while taking this medication, driving or operating hazardous machinery should be avoided. There may be interactions with other medications, so especially if taking anticoagulants, antibiotics, or antiepileptics, inform healthcare professionals. Some medications may require spacing during administration, and when used with antacids, proper time intervals should be maintained. It is safest for pregnant or breastfeeding women not to use this medication, and safety in pediatric patients has not been established, so administration is not recommended. In cases of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and in severe cases, removal through blood dialysis can be considered. This medication may decrease gastric acid secretion, promoting bacterial proliferation in the stomach; therefore, regular check-ups, including eye examinations, are necessary during prolonged use.

Serious side effects

Urticaria, angioedema, anaphylactic shock (severe allergic reaction), severe swelling (edema), chest pain, difficulty breathing, respiratory complications, jaundice, hepatitis, severe liver dysfunction, severe skin reactions, severe neurological symptoms (severe headache, seizures, confusion), severe edema, thrombocytopenia, agranulocytosis, pancytopenia, myelosuppression, aplastic anemia, acquired immune hemolytic anemia

Mild side effects

• Skin rashes
• angioedema
• fever
• bronchospasm
• hypotension
• chest pain
• nausea
• vomiting
• constipation
• diarrhea

This medication may be sensitive to air or moisture, so storing it in a closed container is important. The storage temperature should be maintained between 1 and 30 degrees Celsius, avoiding direct sunlight and high temperatures.

Appearance

Light green rectangular film-coated tablet

Package unit

10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle